- IPC GENERAL
- IPC News
The International Psoriasis Council is governed by a volunteer Board of Directors comprised of the world’s leading experts in psoriasis who provide business expertise to the organization. We are excited to announce the newest IPC leadership changes within the IPC Board of Directors, effective January 1, 2025.
Bruce Strober, MD, PhD, from the United States, will begin his term as President, which will last from 2025 to 2026. Claudia de la Cruz, MD, from Chile, has been elected as Vice President/President-Elect; Catherine Smith, MD, from the United Kingdom, has been elected as Secretary; and Joel Gelfand, MD, PhD, from the United States, will continue to serve as Treasurer. Hervé Bachelez, MD, PhD, from France, will also serve as the Immediate Past President for one more year.
The IPC Board of Directors plays a crucial role in guiding the direction and strategy of our organization as we work to improve psoriasis patient care worldwide.
Please join us in congratulating our newly elected officers and acknowledging their ongoing dedication to the IPC!
Meet Our New Board Officers
Bruce Strober, MD, PhD
Yale University and Central Connecticut Dermatology
Cromwell, Connecticut, United States
IPC President
Joel Gelfand, MD, MSCE
University of Pennsylvania
Philadelphia, Pennsylvania, United States
IPC Treasurer
Catherine Smith, MD
Kings College London, and Guys and St Thomas NHS Foundation Trust
London, United Kingdom
IPC Secretary
Hervé Bachelez, MD, PhD
Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, Paris Cité University
Paris, France
IPC Councilor
A complete list of our Board of Directors with their full biographies can be found here.
